Mecamylamine differentially blocked fast nicotinic transmission in two functional subsets of sympathetic neurons within lumbar paravertebral ganglia of the bullfrog. EC s for inhibition of postsynaptic compound action potentials were 27.3 " 2.5 mM in the 50 secretomotor B system and 5.7 " 0.7 mM in the vasomotor C system. This 5.2:1 selectivity is 2.6 times greater than observed previously with D-tubocurarine, a nonselective blocker of nicotinic receptors, and it indicates that mecamylamine preferentially interacts with nicotinic receptors on sympathetic C neurons. We tested this by analyzing the effect of mecamylamine upon synaptic currents. In both cell types, the drug produced a qualitatively similar picture of open-channel blockade. It reduced EPSC amplitude, speeded EPSC decay, and became more effective with membrane hyperpolarization and repetitive activity. Despite these similarities, 8 mM mecamylamine reduced EPSC amplitude to a greater extent in C neurons, and the rate constant for drug binding to open channels was 4.4 times greater in B cells, irrespective of membrane potential. This implies that the unblocking rate for mecamylamine is much slower in C cells than B cells, and it shows that the drug recognizes a structural difference between nicotinic receptors on these two populations of sympathetic neurons. q 1998 Elsevier Science B.V.
Introduction
The goal of this study was to identify a drug that could distinguish between nicotinic receptors on different sympathetic neurons. We were motivated by emerging evidence that functional subsets of autonomic neurons may express distinct patterns of nicotinic receptor subunits. If true, then selective nicotinic antagonists could provide the means for manipulating different components of autonomic reflexes.
Neuronal nicotinic receptors are a diverse group of pentameric proteins formed by eleven genes which code w x for eight a and three b subunits 26 . Although the postsynaptic receptors mediating fast nicotinic transmission in autonomic ganglia are generally thought to contain two a and three b subunits, their exact subunit stoichiometry remains controversial. The problem arises because native expression of subunits occurs in a complex pattern. Ž . At least five different subunits a 3, a 5, a 7, b 2 and b4 ) Corresponding author. Fax: q 1-412-648-1441; E-mail: jphq@pitt.edu are always found in sympathetic and parasympathetic ganw x glia of the chicken and rat 4, 11, 16, 21, 25 . In some cases, additional subunits are also present; a4 in chicken and rat w x sympathetic ganglia 11,25 , a 2, a4 and b 3 in rat cardiac w x ganglion 21 . At the level of individual neurons, Poth et w x al. 21 found considerable heterogeneity of RNA transcripts for different nicotinic subunits in the mainly parasympathetic rat cardiac ganglion. They also observed a correlation between cellular patterns of nicotinic subunit expression and four types of receptors having distinct single channel conductances. This provided the first molecular evidence that subsets of autonomic neurons may express different nicotinic receptors, but was presaged by w x earlier studies of synaptic currents 17 and receptor expression.
Heterologous expression of cloned nicotinic subunits can produce receptors having distinct pharmacological profiles in addition to differences in single channel conducw x tance and gating 12, 13, 20, 24 . Interestingly, the properties of receptors assembled from pairwise expression of a and b subunits in Xenopus oocytes do not fully match those of w x native receptors on autonomic neurons 5 . These findings ( )lend support to the proposal that synaptic receptors on autonomic neurons normally assemble from three or more w x types of subunits 11,29 , and they provide the best available evidence that antagonists may be useful in distinguishing neuronal receptor subtypes.
Although nicotinic receptors are found on all autonomic ganglion cells, these neurons are phenotypically diverse. w x Beginning with the classical work of Langley 9 , the autonomic nervous system has been conceptualized as having sympathetic, parasympathetic and enteric divisions based on structural and functional grounds. Contemporary efforts have delineated cellular specializations in each division. Within the sympathetics, evidence derived from mammals, birds, and amphibians supports the general principle that postganglionic neurons are heterogeneous in their phenotypic properties and functional roles. In the cat, e.g., as many as thirteen subsets of sympathetic neurons can be differentiated by their target specificity and cellular w x properties 7 . Specialized subsets of neurons selectively control different vascular beds, glands, and piloerector muscles, and they express differences in action potential conduction velocities and in synthesis profiles of transmitw x ters and metabotropic receptors 19 .
In the present work, we focused on bullfrog sympathetic ganglia, a system where the organization of neuronal phenotypes is relatively simple. Paravertebral ganglia 9 and 10 contain only two major cell groups: B neurons w x innervate cutaneous glands 8 and C neurons innervate w x arteries 28 . A difference in the kinetic properties of nicotinic receptors on B and C neurons is evident in w x synaptic currents and acetylcholine noise 17,27 . The time Ž . constant t for exponential decay of the nicotinic EPSC is ; 5 ms in B cells and ; 10 ms in C cells. This implies a difference in the mean duration of individual channel w x openings or bursts of openings 18 . Nicotinic receptors on B and C cells must therefore differ in some aspect of their structure, possibly subunit composition. After screening several compounds with simple extracellular recording, we identified mecamylamine as a drug that appeared selective for the vasomotor C system. Here, we describe these initial experiments and present additional evidence from analysis of synaptic currents that mecamylamine binds with different affinity to receptors on secretomotor B neurons and vasomotor C neurons.
Materials and methods
Preparations of paravertebral ganglia 7-10 were dis-Ž . sected from adult bullfrogs 13-18 cm in length obtained Ž . from Charles D. Sullivan Nashville, TN . Another paper w x 27 details the methods for dissection, selective stimulation of the preganglionic B and C pathways, extracellular recording of postganglionic compound action potentials, 2-electrode voltage-clamp measurements of synaptic currents, and for digitization of the data. Grouped data are expressed as the mean " SEM.
Mecamylamine HCl was obtained from Research Bio-Ž . chemicals Natick, MA . In experiments using extracellular recording to measure dose-response curves, mecamy-Ž . lamine was added to normal Ringer composed of mM Ž . 115 NaCl, 2 KCl, 1.8 CaCl , 4 Na-HEPES pH 7.2 -7.3 .
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In voltage-clamp experiments, the CaCl concentration 2 was raised to 4 mM in order to stabilize the recordings.
Voltage-clamp protocol
Synaptic currents were recorded from individual neurons over a range of three drug concentrations and four holding potentials. During the entire protocol, the presynaptic nerve was continuously stimulated at 0.1 Hz. Measurements of EPSC amplitude and decay were made from averages of 3 responses. After recording control EPSCs in drug-free Ringer, 1 mM mecamylamine was introduced at 3 ml min y1 into the 1 ml recording chamber and allowed to equilibrate for 8-10 min. A family of EPSCs was then recorded at holding potentials of y50, y60, y80, and y100 mV, and the process was repeated for 3 and 8 mM mecamylamine. Only cells that remained stable during the Ž . entire protocol 45-60 min were included in the kinetic analysis.
Analysis of synaptic currents
A simple sequential kinetic model for open-channel block was used to analyze the effect of mecamylamine w x upon EPSC decay 22,23 . The model and the associated Ž reaction rates are shown below A refers to acetylcholine, R to the nicotinic receptor, B to the blocking drug, and w x . X to its concentration. . 
Results
Mecamylamine selectively blocked fast synaptic transmission in the vasomotor C system. Prior to drug addition, postganglionic compound action potentials remained stable when either the preganglionic B or C pathway was selectively stimulated at 0.1 Hz. Fig. 1A illustrates one experiment in which 20 mM mecamylamine produced only partial block of the postsynaptic B wave, but nearly full block of the C wave. Cumulative dose-response curves Ž . compiled from 6 such experiments Fig. 1B showed that the EC for mecamylamine was 27.3 " 2.5 mM in the B 50 pathway and 5.7 " 0.7 mM in the C pathway. The selectivity ratio of EC s in the B and C paths was therefore 5.2:1.
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By comparison, D-tubocurarine has a selectivity ratio of only 2.1:1 when measured in this system using the same Ž .
Ž . Fig. 2 . Mecamylamine inhibits synaptic currents. Families of synaptic currents were recorded from a B neuron A and a C neuron B in drug-free Ringer and 3 doses of mecamylamine. In the upper panels, the dashed lines superimposed on the decay phase of EPSCs are single-exponential fits of the data. The small notch on the decay of the C cell was due to a secondary nicotinic synapse present on this cell. In the lower panels, all EPSCs have been scaled to one amplitude. EPSC decay was slowest in drug-free Ringer and became progressively faster with increasing concentrations of mecamylamine. w x method 27 . In bullfrog sympathetic ganglia, D-tubocurarine acts as a competitive antagonist of nicotinic recepw x tors 10,27 . Selectivity for synapses on C neurons does not arise from a cell-specific difference in drug affinity, but rather from the fact that the nicotinic EPSP in B cells has a larger safety factor for exceeding action potential w x threshold 27 . Since the safety factor is independent of the drug used to block receptors, the larger selectivity observed with mecamylamine shows that it must act through a different mechanism than D-tubocurarine. We tested this hypothesis by recording synaptic currents.
In Ringer containing 4.0 mM Ca 2q , peak EPSC ampli-Ž . tude at y50 mV was 14.3 " 4.6 nA n s 6 in B neurons Ž . and 12.1 " 4.0 nA n s 6 in C neurons. In both cell types, Ž . mecamylamine 1-8 mM inhibited EPSC amplitude and Ž . speeded EPSC decay Fig. 2 . The increases in decay rates are most easily seen after normalizing EPSCs recorded in Ž different drug concentrations to the same amplitude Fig.  . 
2, bottom traces .
The selectivity of mecamylamine for nicotinic transmission in the C pathway suggests that it might preferentially block EPSC amplitude in C neurons. This was the case for 8 mM mecamylamine, but not for lower doses. Fig. 3 Ž . compares the block of ESPC amplitude in B n s 6 vs. C Ž . n s 2 neurons at two drug concentrations. In such a plot, selectivity for receptors on one cell type will result in deviation from the diagonal. All data for 8 mM mecamylamine were to the left of the diagonal, thus indicating a preferential block of receptors on C cells. This effect became slightly larger when the membrane potential was increased from y50 to y100 mV. By contrast, 3 mM mecamylamine was equally effective for receptors on the two cell types.
The shortening of EPSC decay times in mecamylamine indicates it inhibits synaptic transmission by blocking the open nicotinic channel. Before and after exposure to Ž . mecamylamine, EPSCs in both cell types were best fit by a single exponential function rather than as the sum of two Ž . exponentials Fig. 2 . This implies that the unblocking rate for mecamylamine is much slower than the time course of the EPSC, and permits use of a simple method for estimatw x ing the binding rate constant of mecamylamine 23 .
Since mecamylamine is a monovalent cation at physiological pH, its ability to bind to a site within the open nicotinic channel should increase with membrane hyperpolarization, if the site lies within the plane of the membrane. This was indeed the case, as can be seen from representative families of EPSCs recorded at four holding Ž . Ž . potentials in a B cell Fig. 4A and a C cell Fig. 4D . In agreement with previous work, EPSC amplitude increased linearly in drug-free Ringer as the holding potential was w x shifted from y50 to y100 mV 27 . Hyperpolarization of this magnitude causes an approximate doubling of the driving force on synaptic currents which normally reverse near 0 mV in both cell types. In records from individual Ž . Ž neurons Fig. 4A,D and I-V plots of grouped data Fig. . 4B,E , one can see that 8 mM mecamylamine caused modest outward rectification of the I-V relation in six B Ž . cells Fig. 4B and a much stronger effect in two C cells Ž . Fig. 4E . Rectification of this kind is a hallmark of open-channel occlusion which tends to increase as membrane polarization drives the drug into channels.
The voltage-dependence of mecamylamine block was Ž . also evident in time constants t of EPSC decay. Normally, in drug-free Ringer, t itself is voltage-dependent and increases with membrane hyperpolarization in both w x cell types 17,27 . Mecamylamine shifted this relation to the point where, at higher doses, t decreased instead with Ž . hyperpolarization Fig. 4C,F . The data also show that at each holding potential, t decreased as the dose of mecamylamine was increased.
Using a sequential blocking scheme for channel kinetics, we estimated k ) , the binding constant for mecamy- 
where k ) is the rate constant at potentials of V and 0 qB mV, and H ) is the shift in membrane potential that qB produces an e-fold increase of k ) . Grouping the results qB ) Ž . Fig. 6A . In drug-free Ringer, EPSC amplitude was characterized by transient facilitation followed by depression. Increasing the holding potential from y50 mV to y100 mV increased the magnitude of currents without changing the normal progression of facilitation and depression. Consequently, the ratio of normalized EPSC amplitudes recorded at the two potentials remained flat in the Ž . absence of the drug Fig. 6B . By contrast, 3 mM mecamylamine caused the depressed phase of EPSC amplitudes to Ž . become more pronounced at both potentials Fig. 5A . Normalizing the profiles of EPSC amplitudes to drug-free controls showed clear use-dependent accumulation of EPSC Ž . blockade at y50 mV Fig. 6B . Hyperpolarization to y100 mV increased the rate of onset rate and the magnitude of use-dependent block by mecamylamine.
Discussion
We have shown that mecamylamine selectively blocks synaptic transmission in the vasomotor sympathetic C system of the bullfrog, and that it can distinguish between nicotinic receptors on B and C neurons. In both cell types, mecamylamine acts as an open-channel blocker whose efficacy increases with hyperpolarization. At all potentials tested, an 8 mM dose of mecamylamine was more effective in reducing EPSC amplitude in C neurons. Interestingly our estimates of k ) show that the drug binds with qB higher affinity to receptors on B neurons. Given the overall selectivity for C cells this implies that the unblocking rate of mecamylamine must be slower in C than in B neurons.
Could the differential effect of mecamylamine upon synaptic transmission in B and C cells arise from a systematic difference in resting potential? Although difficult to rule out, this possibility seems unlikely. Available reports imply B and C neurons have similar resting potentials in w w x x the range of y50-y 55 mV e.g., Refs. 10,17,27 . In any event, the voltage-clamp data show how mecamylamine can distinguish between receptors on the two cell types.
Our voltage-clamp experiments were done in 4.0 mM calcium to increase the stability of the recordings. When compared with previous measurements in 1.8 mM calcium w x 27 , raising extracellular calcium increased the synaptic conductance and t in both cell types. We did not study the underlying mechanism for these changes but they probably arise from at least three factors; enhanced acetylcholine release, increased calcium current through open nicotinic channels, and increased probability that nicotinic channels w x open in response to acetylcholine 2 .
Mecamylamine has previously been studied in parasymw x pathetic neurons of the rat submandibular ganglion 3,6 . At low concentrations, it has no effect upon channel kinetics and behaves as a competitive blocker of acetylcholine binding to nicotinic receptors. Our finding that drug concentrations F 3 mM are equally effective in B and C cells in blocking EPSC amplitude raises the possibility that another mechanism, possibly competitive, operates in conjunction with open-channel block. At the very least, it shows that a simple open-channel blocking scheme with only one blocked state cannot fully describe mecamylamine's mechanism of action. Interestingly, Ascher et al. w x 3 noted in one of their studies a subset of parasympathetic neurons in which mecamylamine also produced a voltage-dependent block of nicotinic currents. At this time, we cannot account for the differences in mecamylamine action between frog and rat ganglia or within them. Does the range of results reflect fundamental differences between functional groups of autonomic neurons, between amphibians and mammals, or both? This question highlights the basic gaps in available molecular information. The identities of neuronal nicotinic receptor subunits are completely unknown in amphibians, and subunit expression has not been studied in the rat submandibular ganglion. One would expect that fundamental aspects of receptor structure and function are highly conserved based on available comparative data describing muscle and neuronal w x nicotinic receptors in different species 26 . Future cloning of amphibian neuronal nicotinic receptor subunits could provide structural insights into mecamylamine binding and into receptor function in specialized subsets of autonomic neurons.
